Skip to main content
Top
Published in: Journal of Community Health 5/2013

01-10-2013 | Original Paper

Adherence to Repeat Fecal Occult Blood Testing in an Urban Community Health Center Network

Authors: David T. Liss, Anita Petit-Homme, Joe Feinglass, David R. Buchanan, David W. Baker

Published in: Journal of Community Health | Issue 5/2013

Login to get access

Abstract

Annual fecal occult blood testing (FOBT) has the potential to reduce colorectal cancer mortality, but in practice it is challenging to complete FOBT every year. Repeat FOBT adherence may be especially low in community health center (CHC) settings, where many patients face barriers to annual FOBT completion. We conducted a retrospective cohort analysis to investigate adherence to annual FOBT in an urban CHC network that serves a predominantly Spanish-speaking, uninsured adult patient population. This study used data from the two-year period between January 2010 and December 2011, and included adults aged 50–74 who completed a screening FOBT with a negative result during the first 6 months of 2010. We examined whether each patient completed a second FOBT between 9 and 18 months after the initial negative FOBT, and tested whether repeat FOBT adherence was associated with patient characteristics or the number of clinic visits after the initial negative FOBT. Only 69 of 281 included patients completed repeat FOBT (24.6 % adherence), and none of 62 patients (0 %) with 0 clinic visits completed repeat FOBT. We detected no significant differences in adherence by age, sex, preferred language, insurance status, or number of chronic conditions. In multivariable regression, the adjusted relative risk of repeat FOBT was 1.66 (95 % CI 1.09–2.54; p = 0.02) among patients with 3 or more clinic visits (referent: patients with 1–2 visits). The observed low rate of adherence greatly diminishes the effectiveness of FOBT in reducing CRC mortality. Findings demonstrate the need for systems-based interventions that increase adherence without requiring face-to-face encounters.
Literature
1.
go back to reference U.S. Preventive Services Task Force. (2008). Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 149(9), 627–637.CrossRef U.S. Preventive Services Task Force. (2008). Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 149(9), 627–637.CrossRef
2.
go back to reference Zauber, A. G., Lansdorp-Vogelaar, I., Knudsen, A. B., Wilschut, J., van Ballegooijen, M., & Kuntz, K. M. (2008). Evaluating test strategies for colorectal cancer screening: A decision analysis for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 149(9), 659–669.PubMedCrossRef Zauber, A. G., Lansdorp-Vogelaar, I., Knudsen, A. B., Wilschut, J., van Ballegooijen, M., & Kuntz, K. M. (2008). Evaluating test strategies for colorectal cancer screening: A decision analysis for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 149(9), 659–669.PubMedCrossRef
4.
go back to reference Fenton, J. J., Elmore, J. G., Buist, D. S., Reid, R. J., Tancredi, D. J., & Baldwin, L. M. (2010). Longitudinal adherence with fecal occult blood test screening in community practice. Annals of Family Medicine, 8(5), 397–401.PubMedCrossRef Fenton, J. J., Elmore, J. G., Buist, D. S., Reid, R. J., Tancredi, D. J., & Baldwin, L. M. (2010). Longitudinal adherence with fecal occult blood test screening in community practice. Annals of Family Medicine, 8(5), 397–401.PubMedCrossRef
5.
go back to reference Gellad, Z. F., Stechuchak, K. M., Fisher, D. A., et al. (2011). Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. American Journal of Gastroenterology, 106(6), 1125–1134.PubMedCrossRef Gellad, Z. F., Stechuchak, K. M., Fisher, D. A., et al. (2011). Longitudinal adherence to fecal occult blood testing impacts colorectal cancer screening quality. American Journal of Gastroenterology, 106(6), 1125–1134.PubMedCrossRef
6.
go back to reference Mandel, J. S., Bond, J. H., Church, T. R., et al. (1993). Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. New England Journal of Medicine, 328(19), 1365–1371.PubMedCrossRef Mandel, J. S., Bond, J. H., Church, T. R., et al. (1993). Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. New England Journal of Medicine, 328(19), 1365–1371.PubMedCrossRef
7.
go back to reference Kronborg, O., Fenger, C., Olsen, J., Jorgensen, O. D., & Sondergaard, O. (1996). Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet, 348(9040), 1467–1471.PubMedCrossRef Kronborg, O., Fenger, C., Olsen, J., Jorgensen, O. D., & Sondergaard, O. (1996). Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet, 348(9040), 1467–1471.PubMedCrossRef
8.
go back to reference Crawford, N. D., Jones, C. P., & Richardson, L. C. (2010). Understanding racial and ethnic disparities in colorectal cancer screening: Behavioral risk factor surveillance system, 2002 and 2004. Ethnicity and Disease, 20(4), 359–365.PubMed Crawford, N. D., Jones, C. P., & Richardson, L. C. (2010). Understanding racial and ethnic disparities in colorectal cancer screening: Behavioral risk factor surveillance system, 2002 and 2004. Ethnicity and Disease, 20(4), 359–365.PubMed
9.
go back to reference Quick, B. W., Hester, C. M., Young, K. L., & Greiner, K. A. (2013). Self-reported barriers to colorectal cancer screening in a racially diverse, low-income study population. Journal of Community Health, 38(2), 285–292.PubMedCrossRef Quick, B. W., Hester, C. M., Young, K. L., & Greiner, K. A. (2013). Self-reported barriers to colorectal cancer screening in a racially diverse, low-income study population. Journal of Community Health, 38(2), 285–292.PubMedCrossRef
10.
go back to reference Percac-Lima, S., Aldrich, L. S., Gamba, G. B., Bearse, A. M., & Atlas, S. J. (2010). Barriers to follow-up of an abnormal Pap smear in Latina women referred for colposcopy. Journal of General Internal Medicine, 25(11), 1198–1204.PubMedCrossRef Percac-Lima, S., Aldrich, L. S., Gamba, G. B., Bearse, A. M., & Atlas, S. J. (2010). Barriers to follow-up of an abnormal Pap smear in Latina women referred for colposcopy. Journal of General Internal Medicine, 25(11), 1198–1204.PubMedCrossRef
11.
go back to reference Arnold, C. L., Rademaker, A., Bailey, S. C., et al. (2012). Literacy barriers to colorectal cancer screening in community clinics. Journal of Health Communication, 17(Suppl 3), 252–264.PubMedCrossRef Arnold, C. L., Rademaker, A., Bailey, S. C., et al. (2012). Literacy barriers to colorectal cancer screening in community clinics. Journal of Health Communication, 17(Suppl 3), 252–264.PubMedCrossRef
12.
go back to reference Coronado, G., & Thompson, B. (2000). Rural Mexican American men’s attitudes and beliefs about cancer screening. Journal of Cancer Education, 15(1), 41–45.PubMed Coronado, G., & Thompson, B. (2000). Rural Mexican American men’s attitudes and beliefs about cancer screening. Journal of Cancer Education, 15(1), 41–45.PubMed
13.
go back to reference Soneji, S., Iyer, S. S., Armstrong, K., & Asch, D. A. (2010). Racial disparities in stage-specific colorectal cancer mortality: 1960–2005. American Journal of Public Health, 100(10), 1912–1916.PubMedCrossRef Soneji, S., Iyer, S. S., Armstrong, K., & Asch, D. A. (2010). Racial disparities in stage-specific colorectal cancer mortality: 1960–2005. American Journal of Public Health, 100(10), 1912–1916.PubMedCrossRef
14.
go back to reference Alexander, D. D., Waterbor, J., Hughes, T., Funkhouser, E., Grizzle, W., & Manne, U. (2007). African-American and caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review. Cancer Biomarkers, 3(6), 301–313.PubMed Alexander, D. D., Waterbor, J., Hughes, T., Funkhouser, E., Grizzle, W., & Manne, U. (2007). African-American and caucasian disparities in colorectal cancer mortality and survival by data source: an epidemiologic review. Cancer Biomarkers, 3(6), 301–313.PubMed
15.
go back to reference Wang, A., Clouston, S. A., Rubin, M. S., Colen, C. G., & Link, B. G. (2012). Fundamental causes of colorectal cancer mortality: The implications of informational diffusion. Milbank Quarterly, 90(3), 592–618.PubMedCrossRef Wang, A., Clouston, S. A., Rubin, M. S., Colen, C. G., & Link, B. G. (2012). Fundamental causes of colorectal cancer mortality: The implications of informational diffusion. Milbank Quarterly, 90(3), 592–618.PubMedCrossRef
16.
go back to reference Byers, T. (2010). Two decades of declining cancer mortality: Progress with disparity. Annual Review of Public Health, 31, 121–132.PubMedCrossRef Byers, T. (2010). Two decades of declining cancer mortality: Progress with disparity. Annual Review of Public Health, 31, 121–132.PubMedCrossRef
18.
go back to reference Zou, G. (2004). A modified poisson regression approach to prospective studies with binary data. American Journal of Epidemiology, 159(7), 702–706.PubMedCrossRef Zou, G. (2004). A modified poisson regression approach to prospective studies with binary data. American Journal of Epidemiology, 159(7), 702–706.PubMedCrossRef
19.
go back to reference Doubeni, C. A., Laiyemo, A. O., Young, A. C., et al. (2010). Primary care, economic barriers to health care, and use of colorectal cancer screening tests among medicare enrollees over time. Annals of Family Medicine, 8(4), 299–307.PubMedCrossRef Doubeni, C. A., Laiyemo, A. O., Young, A. C., et al. (2010). Primary care, economic barriers to health care, and use of colorectal cancer screening tests among medicare enrollees over time. Annals of Family Medicine, 8(4), 299–307.PubMedCrossRef
20.
go back to reference Seeff, L. C., Nadel, M. R., Klabunde, C. N., et al. (2004). Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer, 100(10), 2093–2103.PubMedCrossRef Seeff, L. C., Nadel, M. R., Klabunde, C. N., et al. (2004). Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer, 100(10), 2093–2103.PubMedCrossRef
21.
go back to reference Ioannou, G. N., Chapko, M. K., & Dominitz, J. A. (2003). Predictors of colorectal cancer screening participation in the United States. American Journal of Gastroenterology, 98(9), 2082–2091.PubMedCrossRef Ioannou, G. N., Chapko, M. K., & Dominitz, J. A. (2003). Predictors of colorectal cancer screening participation in the United States. American Journal of Gastroenterology, 98(9), 2082–2091.PubMedCrossRef
22.
go back to reference Committee on Quality of HealthCare in America. (2001). Crossing the quality chasm: A new health system for the twenty-first century. Washington, DC: Institute of Medicine. Committee on Quality of HealthCare in America. (2001). Crossing the quality chasm: A new health system for the twenty-first century. Washington, DC: Institute of Medicine.
23.
go back to reference Mosen, D. M., Feldstein, A. C., Perrin, N., et al. (2010). Automated telephone calls improved completion of fecal occult blood testing. Medical Care, 48(7), 604–610.PubMedCrossRef Mosen, D. M., Feldstein, A. C., Perrin, N., et al. (2010). Automated telephone calls improved completion of fecal occult blood testing. Medical Care, 48(7), 604–610.PubMedCrossRef
24.
go back to reference Myers, R. E., Sifri, R., Hyslop, T., et al. (2007). A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer, 110(9), 2083–2091.PubMedCrossRef Myers, R. E., Sifri, R., Hyslop, T., et al. (2007). A randomized controlled trial of the impact of targeted and tailored interventions on colorectal cancer screening. Cancer, 110(9), 2083–2091.PubMedCrossRef
25.
go back to reference Liles, E. G., Perrin, N., Rosales, A. G., et al. (2012). Change to FIT increased CRC screening rates: evaluation of a U.S. screening outreach program. American Journal of Managed Care, 18(10), 588–595.PubMed Liles, E. G., Perrin, N., Rosales, A. G., et al. (2012). Change to FIT increased CRC screening rates: evaluation of a U.S. screening outreach program. American Journal of Managed Care, 18(10), 588–595.PubMed
26.
go back to reference Federici, A., Giorgi Rossi, P., Borgia, P., Bartolozzi, F., Farchi, S., & Gausticchi, G. (2005). The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: A cluster randomized controlled trial. Journal of Medical Screening, 12(2), 83–88.PubMedCrossRef Federici, A., Giorgi Rossi, P., Borgia, P., Bartolozzi, F., Farchi, S., & Gausticchi, G. (2005). The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: A cluster randomized controlled trial. Journal of Medical Screening, 12(2), 83–88.PubMedCrossRef
27.
go back to reference Hoffman, R. M., Steel, S., Yee, E. F., Massie, L., Schrader, R. M., & Murata, G. H. (2010). Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: A randomized, controlled trial. Preventive Medicine, 50(5–6), 297–299.PubMedCrossRef Hoffman, R. M., Steel, S., Yee, E. F., Massie, L., Schrader, R. M., & Murata, G. H. (2010). Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: A randomized, controlled trial. Preventive Medicine, 50(5–6), 297–299.PubMedCrossRef
Metadata
Title
Adherence to Repeat Fecal Occult Blood Testing in an Urban Community Health Center Network
Authors
David T. Liss
Anita Petit-Homme
Joe Feinglass
David R. Buchanan
David W. Baker
Publication date
01-10-2013
Publisher
Springer US
Published in
Journal of Community Health / Issue 5/2013
Print ISSN: 0094-5145
Electronic ISSN: 1573-3610
DOI
https://doi.org/10.1007/s10900-013-9685-x

Other articles of this Issue 5/2013

Journal of Community Health 5/2013 Go to the issue